FibroGen (FGEN) Tops Q3 EPS by 55c; Reports Cash and Cash Equivalents of $665.0M

November 9, 2021 4:29 PM EST

FibroGen (NASDAQ: FGEN) reported Q3 EPS of $0.54, $0.55 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $156 million versus the consensus estimate of $143.46 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Earnings

Related Entities